The Evolving Face of Indian Clinical Research & Regulatory Shifts
The Indian pharmaceutical landscape is undergoing a massive shift, driven by regulatory harmonization and a digital-first approach to R&D. In […]
AI-IN-CLINICAL-TRIALS
The Digital Transformation of Pharma and Clinical Research in India
A veteran leader in global clinical trials and pharmacovigilance, Dr. Shubhadeep D. Sinha, Senior VP and Head- Clinical Development & […]
AIM-NASH: First-Ever Digital Pathology Tool Approved by FDA for Liver Drug Trials
A major milestone for AI-driven drug development, the U.S. Food and Drug Administration (FDA) has officially qualified AIM-NASH, the first […]
